Grimes & Company Inc. decreased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,340 shares of the healthcare conglomerate’s stock after selling 1,253 shares during the quarter. Grimes & Company Inc.’s holdings in UnitedHealth Group were worth $6,726,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the stock. Edgestream Partners L.P. raised its holdings in shares of UnitedHealth Group by 435.5% in the 1st quarter. Edgestream Partners L.P. now owns 22,833 shares of the healthcare conglomerate’s stock valued at $3,745,000 after buying an additional 18,569 shares during the period. Colonial Trust Advisors raised its holdings in shares of UnitedHealth Group by 1.7% in the 1st quarter. Colonial Trust Advisors now owns 34,143 shares of the healthcare conglomerate’s stock valued at $5,918,000 after buying an additional 570 shares during the period. Fiduciary Trust Co. raised its holdings in shares of UnitedHealth Group by 75.6% in the 1st quarter. Fiduciary Trust Co. now owns 37,349 shares of the healthcare conglomerate’s stock valued at $6,126,000 after buying an additional 16,080 shares during the period. Baker Avenue Asset Management LP purchased a new stake in shares of UnitedHealth Group in the 1st quarter valued at $765,000. Finally, Flagship Harbor Advisors LLC raised its holdings in shares of UnitedHealth Group by 50.6% in the 1st quarter. Flagship Harbor Advisors LLC now owns 5,013 shares of the healthcare conglomerate’s stock valued at $823,000 after buying an additional 1,684 shares during the period. Hedge funds and other institutional investors own 86.21% of the company’s stock.
Several equities research analysts recently issued reports on UNH shares. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald boosted their target price on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Wells Fargo & Co reissued an “outperform” rating and set a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Finally, Evercore ISI reissued an “outperform” rating and set a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a research note on Friday, January 12th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $243.22.
Shares of UnitedHealth Group Inc (NYSE UNH) traded up $0.13 during midday trading on Wednesday, hitting $236.78. The company had a trading volume of 5,145,057 shares, compared to its average volume of 3,450,000. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The firm has a market cap of $228,930.00, a PE ratio of 22.11, a PEG ratio of 1.44 and a beta of 0.66. UnitedHealth Group Inc has a 1 year low of $156.49 and a 1 year high of $250.79.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm’s revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the business earned $2.11 EPS. research analysts forecast that UnitedHealth Group Inc will post 12.51 EPS for the current year.
In other news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,853 shares of company stock valued at $9,980,908. 0.89% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Grimes & Company Inc. Has $6.73 Million Holdings in UnitedHealth Group Inc (NYSE:UNH)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/31/grimes-company-inc-reduces-holdings-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.